![](https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/gty_220118_migraine_patient_doctor_800x450.jpg)
New Guidance on CGRPs: How/Will it Shape Clinical Practice?
A position statement released by the American Headache Society (AHS) earlier this year recommended adding calcitonin gene-related peptide (CGRP)–targeting medications to the list of first-line therapies for migraine prevention. The guidance replaces …